A Framework for Understanding and Managing ‘The Diabetes Syndrome’: A Unified Pathophysiologic Approaching the Context of the Beta-Cell Classification of Diabetes
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Key messages
- Classification of DM should change- we've learned so much more re: pathophysiology.
- Note: same pathophysiologies that damage beta-cells are related to risk of specific Diabetic Complications.
- Conditions that are epidemiologically and pathophysiologically related to DM.
- We've thus defined these connections as THE DIABETES SYNDROME.
- Defines a logical process for implementing Precision Medicine.
Presenting Author
Stanley Schwartz, MD, FACP
Emeritus Clinical assoc. Prof. of Medicine, Univ of Pa.
Dr. Stanley Schwartz is currently in a private practice in Ardmore, Pa., after having spent 32 years at the Univ. Pa. Dr. Schwartz received his MD in 1973 from the University of Chicago; completed his residency at the University of Pennsylvania; and did a fellowship in endocrinology and metabolism at the University of Chicago.
Dr. Schwartz actively lectures nationally, as well as internationally, about diabetes and its treatment. He has authored numerous articles in peer-reviewed scientific journals and has been a lead or co-investigator for many clinical trials (DCCT-EDIC, LOOK AHEAD). He has created and proposed a New Classification and Unified Pathophysiologic Construct for All Diabetes -now published in Diabetes Care, and Trends in Endocrinology.
He’s been elected by his peers for inclusion in Best Doctors in America® from 1996 to 2018 and is a recipient of Marquis Who's Who l 2018/2019 Albert Nelson Marquis Lifetime Achievement Award. Though he does some research and teaches a great deal, most of his time is spent caring for patients.
Author disclosures
Please see Meeting App for Conflict of Interest Statement
